Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Vaessen

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Transplantation Proceedings|December 1, 1996
Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trialT van Gelder, R Zietse, J N Yzermans, et al.
Clinical and Experimental Immunology|December 14, 1999
T helper frequencies in peripheral blood reflect donor-directed reactivity in the graft after clinical heart transplantationL M Vaessen, C R Daane, A P Maat, et al.
Transplant Immunology|September 27, 2000
Modulation of the T cell receptor beta chain repertoire after heart transplantationK Doumaid, P P van Miert, L M Vaessen, et al.
Clinical and Experimental Immunology|July 27, 2001
Increased numbers of circulating donor-specific T helper lymphocytes after human heart valve transplantationM J Welters, F B Oei, L M Vaessen, et al.
The Annals of Thoracic Surgery|June 5, 2001
Immunological aspects of fresh and cryopreserved aortic valve transplantation in ratsF B Oei, A P Stegmann, L M Vaessen, et al.
Transplantation Proceedings|April 1, 1988
The effect of long-term cyclosporine therapy on natural killer cell activityD J Versluis, H J Metselaar, A M Bijma, et al.
Transplantation Proceedings|December 1, 1996
CsA therapy affects the direct and indirect antigen-presentation pathway in cardiac allograft recipientsN M van Besouw, L M Vaessen, A H Balk, et al.
Transplantation|May 15, 1997
Donor-specific cytokine production by graft-infiltrating lymphocytes induces and maintains graft vascular disease in human cardiac allograftsN M van Besouw, C R Daane, L M Vaessen, et al.
Transplant Immunology|June 2, 2000
Donor-derived soluble HLA plasma levels can not be used to monitor graft rejection in heart transplant recipientsC A Koelman, L M Vaessen, A H Balk, et al.
Transplantation|August 27, 1996
Progressive accumulation of CTL with high avidity for donor antigens during the development of acute cardiac rejectionN E van Emmerik, L M Vaessen, A H Balk, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Transplantation Proceedings|December 1, 1996
Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trialT van Gelder, R Zietse, J N Yzermans, et al.
Clinical and Experimental Immunology|December 14, 1999
T helper frequencies in peripheral blood reflect donor-directed reactivity in the graft after clinical heart transplantationL M Vaessen, C R Daane, A P Maat, et al.
Transplant Immunology|September 27, 2000
Modulation of the T cell receptor beta chain repertoire after heart transplantationK Doumaid, P P van Miert, L M Vaessen, et al.
Clinical and Experimental Immunology|July 27, 2001
Increased numbers of circulating donor-specific T helper lymphocytes after human heart valve transplantationM J Welters, F B Oei, L M Vaessen, et al.
The Annals of Thoracic Surgery|June 5, 2001
Immunological aspects of fresh and cryopreserved aortic valve transplantation in ratsF B Oei, A P Stegmann, L M Vaessen, et al.
Transplantation Proceedings|April 1, 1988
The effect of long-term cyclosporine therapy on natural killer cell activityD J Versluis, H J Metselaar, A M Bijma, et al.
Transplantation Proceedings|December 1, 1996
CsA therapy affects the direct and indirect antigen-presentation pathway in cardiac allograft recipientsN M van Besouw, L M Vaessen, A H Balk, et al.
Transplantation|May 15, 1997
Donor-specific cytokine production by graft-infiltrating lymphocytes induces and maintains graft vascular disease in human cardiac allograftsN M van Besouw, C R Daane, L M Vaessen, et al.
Transplant Immunology|June 2, 2000
Donor-derived soluble HLA plasma levels can not be used to monitor graft rejection in heart transplant recipientsC A Koelman, L M Vaessen, A H Balk, et al.
Transplantation|August 27, 1996
Progressive accumulation of CTL with high avidity for donor antigens during the development of acute cardiac rejectionN E van Emmerik, L M Vaessen, A H Balk, et al.
Pageof 9